{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T12:03:26Z","timestamp":1779969806987,"version":"3.53.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004900","name":"Secretariat for Economic Development of Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004900","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Minas Gerais State Foundation of Support to the Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.parint.2026.103256","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:43:34Z","timestamp":1772264614000},"page":"103256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Therapeutic efficacy of a novel immunotherapeutic formulation, combining a multi-epitope chimeric protein and Amphotericin B, in murine L. infantum infection"],"prefix":"10.1016","volume":"114","author":[{"given":"J\u00falia Kelly","family":"Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scarleth Silva","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naianda Rezende","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Pagliara","family":"Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza","family":"dos Reis Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Jos\u00e9 Lucas","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago Miranda","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Clara","family":"Moura e Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle Caroline","family":"de Souza Dutra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Andrez Machado","family":"de \u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria Ravena Severino","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00edbia Mariana","family":"Eleut\u00e9rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Salles Moura","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Antonio Ferraz","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Mendes","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Menezes-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Costa","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.parint.2026.103256_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004349","article-title":"A historical overview of the classification, evolution, and dispersion of Leishmania parasites and sandflies","volume":"10","author":"Akhoundi","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"6","key":"10.1016\/j.parint.2026.103256_bb0025","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.cvsm.2022.06.012","article-title":"Leishmaniasis","volume":"52","author":"Baneth","year":"2022","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"issue":"1","key":"10.1016\/j.parint.2026.103256_bb0235","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pt.2019.10.006","article-title":"Leishmania infantum","volume":"36","author":"Serafim","year":"2020","journal-title":"Trends Parasitol."},{"issue":"6","key":"10.1016\/j.parint.2026.103256_bb0020","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/infdis\/154.6.1003","article-title":"New perspectives on a subclinical form of visceral leishmaniasis","volume":"154","author":"Badaro","year":"1986","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.parint.2026.103256_bb0065","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.parint.2026.103256_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/clinids\/22.1.1","article-title":"Clinical spectrum of Leishmaniasis","volume":"22","author":"Pearson","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.parint.2026.103256_bb0270","series-title":"World Helth Organization","first-page":"2023","author":"WHO","year":"2023"},{"issue":"7090","key":"10.1016\/j.parint.2026.103256_bb0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.parint.2026.103256_bb0035","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.pt.2024.07.013","article-title":"The immunomicrotope of Leishmania control and persistence","volume":"40","author":"Bogdan","year":"2024","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.parint.2026.103256_bb0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12703\/P6-13","article-title":"The M1 and M2 paradigm of macrophage activation: time for reassessment","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000Prime Rep."},{"issue":"5891","key":"10.1016\/j.parint.2026.103256_bb0190","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1126\/science.1159194","article-title":"In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies","volume":"321","author":"Peters","year":"2008","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.parint.2026.103256_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186117","article-title":"Efficacy of azole therapy for tegumentary leishmaniasis: a systematic review and meta-analysis","volume":"12","author":"Galvao","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.parint.2026.103256_bb0255","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1017\/S0031182017002116","article-title":"Chemotherapeutics of visceral leishmaniasis: present and future developments","volume":"145","author":"Sundar","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.parint.2026.103256_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2022.106661","article-title":"Amphotericin B: a drug of choice for visceral Leishmaniasis","volume":"235","author":"Kumari","year":"2022","journal-title":"Acta Trop."},{"issue":"12","key":"10.1016\/j.parint.2026.103256_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.parint.2026.103256_bb0250","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0974-777X.62886","article-title":"Liposomal amphotericin B and leishmaniasis: dose and response","volume":"2","author":"Sundar","year":"2010","journal-title":"J. Global Infect. Dis."},{"issue":"2","key":"10.1016\/j.parint.2026.103256_bb0260","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.trstmh.2010.10.008","article-title":"Ambisome plus miltefosine for Indian patients with kala-azar","volume":"105","author":"Sundar","year":"2011","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"7","key":"10.1016\/j.parint.2026.103256_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008439","article-title":"Unravelling the proteomic signature of extracellular vesicles released by drug-resistant Leishmania infantum parasites","volume":"14","author":"Douanne","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.parint.2026.103256_bb0115","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fcimb.2019.00427","article-title":"An overview of immunotherapeutic approaches against canine visceral Leishmaniasis: what has been tested on dogs and a new perspective on improving treatment efficacy","volume":"9","author":"Goncalves","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"7","key":"10.1016\/j.parint.2026.103256_bb0125","article-title":"A recombinant chimeric protein-based vaccine containing T-cell epitopes from amastigote proteins and combined with distinct adjuvants, induces immunogenicity and protection against Leishmania infantum infection","volume":"10","author":"Lage","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.parint.2026.103256_bb0265","article-title":"Efficacy of an immunotherapy combining immunogenic chimeric protein plus adjuvant and amphotericin B against murine visceral Leishmaniasis","volume":"12","author":"Vale","year":"2023","journal-title":"Biol.-Basel"},{"issue":"2","key":"10.1016\/j.parint.2026.103256_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12020314","article-title":"Immunotherapy using immunogenic Mimotopes selected by phage display plus amphotericin B inducing a therapeutic response in mice infected with Leishmania amazonensis","volume":"12","author":"Soyer","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.parint.2026.103256_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2023.106986","article-title":"The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice","volume":"246","author":"Lage","year":"2023","journal-title":"Acta Trop."},{"issue":"2","key":"10.1016\/j.parint.2026.103256_bb0040","article-title":"Chimeric vaccines designed by immunoinformatics-activated polyfunctional and memory T cells that trigger protection against experimental visceral leishmaniasis","volume":"8","author":"Brito","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"21","key":"10.1016\/j.parint.2026.103256_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126178","article-title":"CD4(+) and CD8(+) T-cell multi-epitope chimeric protein associated with an MPLA adjuvant induce protective efficacy and long-term immunological memory for the immunoprophylaxis of American Tegumentary Leishmaniasis","volume":"42","author":"Moura","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.parint.2026.103256_bb0205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.coi.2020.08.008","article-title":"New horizons in adjuvants for vaccine development","volume":"65","author":"Reed","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.parint.2026.103256_bb0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpb.2016.05.018","article-title":"PLGA nanoparticles modified with a TNFalpha mimicking peptide, soluble Leishmania antigens and MPLA induce T cell priming in vitro via dendritic cell functional differentiation","volume":"105","author":"Margaroni","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.parint.2026.103256_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2023.106865","article-title":"Immunoproteomics approach for the discovery of antigens applied to the diagnosis of canine visceral leishmaniasis","volume":"241","author":"Costa","year":"2023","journal-title":"Acta Trop."},{"key":"10.1016\/j.parint.2026.103256_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.rvsc.2025.105820","article-title":"Potential immunoprophylactic use of a multi-epitope protein of CD4(+) and CD8(+) T cells against visceral leishmaniasis in Balb\/c mice","volume":"194","author":"Costa","year":"2025","journal-title":"Res. Vet. Sci."},{"issue":"7","key":"10.1016\/j.parint.2026.103256_bb0050","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.parint.2026.103256_bb0200","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-60327-118-9_13","article-title":"Prediction of peptide-MHC binding using profiles","volume":"409","author":"Reche","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.parint.2026.103256_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cellimm.2017.11.001","article-title":"Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis","volume":"323","author":"Dias","year":"2018","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.parint.2026.103256_bb0135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1745-7580-2-2","article-title":"Improved method for predicting linear B-cell epitopes","volume":"2","author":"Larsen","year":"2006","journal-title":"Immunome Res."},{"issue":"11","key":"10.1016\/j.parint.2026.103256_bb0080","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/CVI.00465-15","article-title":"Proteins selected in Leishmania (Viannia) braziliensis by an Immunoproteomic approach with potential Serodiagnosis applications for Tegumentary Leishmaniasis","volume":"22","author":"Duarte","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"issue":"18","key":"10.1016\/j.parint.2026.103256_bb0105","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.1007\/s00253-021-11518-1","article-title":"Development of a chimeric protein based on a proteomic approach for the serological diagnosis of human tegumentary leishmaniasis","volume":"105","author":"Garcia","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.parint.2026.103256_bb0160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cellimm.2016.12.008","article-title":"A recombinant fusion protein displaying murine and human MHC class I- and II-specific epitopes protects against Leishmania amazonensis infection","volume":"313","author":"Martins","year":"2017","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.parint.2026.103256_bb0220","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molimm.2018.12.025","article-title":"Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection","volume":"106","author":"Ribeiro","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.parint.2026.103256_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114306","article-title":"Development of a topical treatment for tegumentary leishmaniasis using 8-hydroxyquinoline","volume":"199","author":"Rezende Ribeiro","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.parint.2026.103256_bb0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.molimm.2016.06.014","article-title":"A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection","volume":"76","author":"Duarte","year":"2016","journal-title":"Mol. Immunol."},{"issue":"12","key":"10.1016\/j.parint.2026.103256_bb0015","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1007\/s00253-022-12033-7","article-title":"Development of an immunogen containing CD4(+)\/CD8(+) T-cell epitopes for the prophylaxis of tegumentary leishmaniasis","volume":"106","author":"de Andrade Ferraz","year":"2022","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.parint.2026.103256_bb0140","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7010.1","article-title":"Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells","volume":"4","author":"Ma","year":"2015","journal-title":"F1000Res"},{"issue":"4","key":"10.1016\/j.parint.2026.103256_bb0175","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1189\/jlb.69.4.598","article-title":"Requirement for STAT1 in LPS-induced gene expression in macrophages","volume":"69","author":"Ohmori","year":"2001","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.parint.2026.103256_bib281","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.parint.2026.103256_bib282","doi-asserted-by":"crossref","first-page":"e2148","DOI":"10.1371\/journal.pntd.0002148","article-title":"Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis","volume":"7","author":"Martins","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"10","key":"10.1016\/j.parint.2026.103256_bb0090","first-page":"623","article-title":"Current status and perspectives of the immunotherapy of leishmaniasis","volume":"11","author":"El-On","year":"2009","journal-title":"Isr. Med. Assoc. J."},{"issue":"5","key":"10.1016\/j.parint.2026.103256_bb0110","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0738-081X(96)00040-5","article-title":"Vaccine for prophylaxis and immunotherapy, Brazil","volume":"14","author":"Genaro","year":"1996","journal-title":"Clin. Dermatol."},{"issue":"9","key":"10.1016\/j.parint.2026.103256_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000818","article-title":"Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent","volume":"4","author":"Meheus","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.parint.2026.103256_bb0225","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2014.00272","article-title":"Immunotherapy and Immunochemotherapy in visceral Leishmaniasis: promising treatments for this neglected disease","volume":"5","author":"Roatt","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.parint.2026.103256_bb0275","article-title":"Immunotherapy and immunochemotherapy in combating visceral leishmaniasis","volume":"10","author":"Yadagiri","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"issue":"21","key":"10.1016\/j.parint.2026.103256_bb0230","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1007\/s00253-020-10856-w","article-title":"Recent advances and new strategies on leishmaniasis treatment","volume":"104","author":"Roatt","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"11","key":"10.1016\/j.parint.2026.103256_bb0095","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.pt.2004.08.009","article-title":"Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis","volume":"20","author":"Engwerda","year":"2004","journal-title":"Trends Parasitol."},{"issue":"1","key":"10.1016\/j.parint.2026.103256_bb0155","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12359","article-title":"A recombinant chimeric protein composed of human and mice-specific CD4(+) and CD8(+) T-cell epitopes protects against visceral leishmaniasis","volume":"39","author":"Martins","year":"2017","journal-title":"Parasite Immunol."},{"issue":"1\u20133","key":"10.1016\/j.parint.2026.103256_bb0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.vetimm.2008.10.307","article-title":"Systemic and compartmentalized immune response in canine visceral leishmaniasis","volume":"128","author":"Reis","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"4","key":"10.1016\/j.parint.2026.103256_bb0240","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0304-4017(00)00446-5","article-title":"Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment","volume":"96","author":"Solano-Gallego","year":"2001","journal-title":"Vet. Parasitol."},{"issue":"9","key":"10.1016\/j.parint.2026.103256_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010779","article-title":"Amphotericin B resistance in Leishmania mexicana: alterations to sterol metabolism and oxidative stress response","volume":"16","author":"Alpizar-Sosa","year":"2022","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576926000279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576926000279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T11:17:22Z","timestamp":1779967042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383576926000279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":55,"alternative-id":["S1383576926000279"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2026.103256","relation":{},"ISSN":["1383-5769"],"issn-type":[{"value":"1383-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic efficacy of a novel immunotherapeutic formulation, combining a multi-epitope chimeric protein and Amphotericin B, in murine L. infantum infection","name":"articletitle","label":"Article Title"},{"value":"Parasitology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parint.2026.103256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103256"}}